Cleo Diagnostics Ltd (ASX:COV)
Australia · Delayed Price · Currency is AUD 0.6400
-0.0500 (-7.25%)
At close: May 18, 2026
Cleo Diagnostics Market Cap
Cleo Diagnostics has a market cap or net worth of 87.59 million as of May 18, 2026. Its market cap has increased by 67.28% in one year.
Market Cap
87.59M
Enterprise Value
78.17M
Revenue
2.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.64
Market Cap Chart
Since August 15, 2023, Cleo Diagnostics's market cap has increased from 25.70M to 87.59M, an increase of 240.82%. That is a compound annual growth rate of 56.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 94.43M | 14.05% |
| Dec 31, 2025 | 82.80M | 81.51% |
| Dec 31, 2024 | 45.62M | 102.86% |
| Dec 29, 2023 | 22.49M | -12.50% |
| Aug 15, 2023 | 25.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EBR Systems | 254.56M |
| Aroa Biosurgery | 214.46M |
| EMVision Medical Devices | 162.18M |
| SomnoMed | 124.88M |
| Saluda Medical | 120.97M |
| Lumos Diagnostics Holdings | 115.48M |
| Epiminder | 93.03M |
| Compumedics | 55.93M |